e-ISSN: 2664-1194     print ISSN: 2304-6554
İmmun çatışmazlıq olan uşaqlara yanaşma
Azərbaycan Perinatologiya və Pediatriya Jurnalı

Annotasiya

İmmun sistemin çatışmazlığı - bir və ya daha çox hüceyrə qrupunda hüceyrə liqandı, zülal, sitokin, sitokin reseptoru çatışmazlığı nəticəsində yaranan, infeksion proseslərə meyilliyi artıran, autoimmun və limfoproliferasiyaya səbəb olan xəstəliklər qrupudur. Birincili (ilkin) immun çatışmazlıq (BİÇ) xəstəlikləri, immun sistemin inkişafına və/və ya funksiyasına təsir edən anadangəlmə qüsurdur. Xəstəliyin ilkin əlamətləri doğuşdan dər- hal sonra başlaya bilər, daha çox hallarda özünü intrasellulyar viral infeksiyalar şəklində büruzə verər.

Biblioqrafik istinadlar

Ç.Aydoğmuş, R.Şiraneci. İmmün Yetersizlikte Tanısal Yaklaşım; JOPP Derg 2(2):52-54, 2010

M.Sütçü, A.Somer. Çocuklarda İmmün Yetmezliklere Yaklaşım, Çocuk Dergisi 14(2):62-65, 2014

Arkwright PD, GenneryAR.Ten warning signs of primary immunodeficiency: a new paradigm is needed for the 21st century. Ann AcadSci 2011;1238:7-14.

T.Turul, İ.Tez. Primer İmmun Yetmezlik Hastalıklarına yaklaşım, 2003,cilt 12

DeVries E, Driessen G. Educational paper: primary immunodeficiencies in children: a diagnostic challenge. Eur J Pediatr. 2011;170(2):169–177.

D.Ç.Ayvaz; Primer immun yetmezliklere yaklaşım,; Katkı Pediatri Dergisi 2011; 33 (2);85-98.

FM Tosi. Normal and Impaired Immunologic Responses to Infection. Textbook of Pediatric Infectious D., 7th Edition, Philadelphia. 2014: 55-106.

Dhrubajyoti Sharma et al.Approach to a Child with Primary Immunodeficiency Made Simple, Indian Dermatol J. 2017 Nov-Dec; 8(6): 391–405.

Norouzi S, Aghamohammadi A, Mamishi S and etc. BCG complications associated with primary immunodeficiency diseases. J Infect 2012;64:543-54

Aziz Bousfiha, LeïlaJeddane et al.The 2017 IUIS Phenotypic Classification for Primary Immunodeficiencies;J ClinImmunol. 2018; 38(1): 129–143.

Notarangelo LD, Fischer A, Geha RS, et al; Primary immunodeficiencies: J Allergy ClinImmunol. 2009; 124(6):1161–1178.

De Vries E.Patient-center screening for primary immunodeficiency:a multistage diagnostic protocol designed for non-Immunologists.Immunol 2006: 204-14.

Casanova JL, Abel L. Primary immunodeficiencies: a field in its infancy. Science 2007; 317:617-9.

Orange JS. Clinical update in immunoglobulin therapy for primary immunodeficiency diseases; Immune Deficiency Foundation; 2012.

Notarangelo LD. Primary immunodeficiencies. J Allergy ClinImmunol 2010; 125:182-94.

Picard C, Al-Herz W, Bousfiha A, et al. Primary Immunodeficiency Diseases: J ClinImmunol. 2015; 35:696–726.

Buckley HR. Evaluation of suspected immunodeficiency. In: Behrman RE, Kliegman RM.18th ed. Philadelphia: Saunders, 2007: 867-73.

Gathmann B, Grimbacher B, Beauté J, et al.; The European Internet-based patient and research database for primary immunodeficiencies: 2009; 157:3-11.

ARIN E. REUST, MD, MSPH, University of Missouri School of Medicine, Columbia. 2013 Jun 1;87(11):773-778

Joshi AY, Iyer VN, Hagan JB et al. Incidence and temporal trends of primary immunodeficiency: a population-based cohort study. 2009; 84(1):16–22.

E.Ayaşlıoğlu. Hücresel İmmün Yetmezlikler ve İnfeksiyon, Kırıkkale Üniversitesi Tıp Fakültesi 2014: 4:142-149.

Hauk PJ, Johnston RB,et al. Immunodeficiency evaluation: primary considerations. Pediatrics 20th ed. Columbus,: December 1, 2011

Slatter MA, Gennery AR. Clinical immunology review series: an approach to the patient with recurrent infections in childhood. 2008; 152(3):389–396.

Turvey SE, Bonilla FA, Junker AK. Primary immunodeficiency diseases: a practical guide for clinicians. Postgrad Med J 2009; 85:660-6.

Singh S, Gupta S. Primary Immunodeficiency Diseases: Need for Awareness and Advocacy in India. Indian J Pediatr. 2016; 83:328–30.

Cunningham-Rundles C. Autoimmunity in primary immune deficiency: Taking lessons from our patients. ClinExpImmunol. 2011;164:6–11.

Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines November 5, 2012.

Immune Deficiency Foundation SCID Newborn Screening. New year, new updates on SCID screening. Accessed December 11, 2012.

Railey MD, Lokhnygina Y et al. Long-term clinical outcome of patients with SCİD who received related donor bone marrow transplants or post-transplant GVHD prophylaxis. J Pediatr. 2009;155(6):834–840.e1.

Lipstein EA, Vorono S, et al. Systematic evidence review of newborn screening and treatment of SCİD. Pediatrics. 2010;125(5):e1226–e1235.

Routes JM, Grossman WJ, Verbsky J, et al. Statewide newborn screening for severe T- cell lymphopenia. JAMA. 2009;302(22):2465–2470.

Comeau AM, Hale JE, Pai SY, et al. Guidelines for implementation of population-based newborn screening for SCİD. 2010;33:S273–S281.

Vaccination of Persons with Primary and Secondary İmmune Deficiencies. Table 8- 1,ACIP General Best Practice Guidelines for Immuniz.; March 2018.

PDF
PDF

Açar sözlər

immune system
primary immunodeficiency
secondary immunodeficiency immun sistem
primer immun çatışmazlıq
ikincili immun çatışmazlıq иммунная система
первичный иммунодефицит
вторичныйиммуно- дефицит